Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:07am, Tuesday, May 13, 2025
Monopar Therapeutics Inc. (NASDAQ: MNPR) has recently released its financial results for the first quarter ended March 31, 2025. Below is an overview of the company's financial performance and key points from the income statement.
Financial Highlights
Net Loss: The company's net loss was $2.625 ...
09:07am, Tuesday, May 13, 2025
NeuroOne Medical Technologies Corporation (OTCBB: NMTC) is focused on developing and commercializing thin film electrode technology for a variety of neurological applications. The company announced its quarterly results for the period ending March 31, 2025, revealing both positive performance met...
09:06am, Tuesday, May 13, 2025
Ovid Therapeutics Inc. (NASDAQ: OVID) is currently navigating through a complex financial situation as it focuses on the development of pharmacological solutions for brain conditions. Here’s a breakdown of the essential details surrounding their latest financial performance and key developments.
...
09:06am, Tuesday, May 13, 2025
MeiraGTx Holdings plc (NASDAQ: MGTX) is a clinical-stage gene therapy company facing continued financial challenges as indicated in its recent quarterly report for Q1 2025.
Key Points from the Q1 2025 Income Statement:
Service revenue increased to $1.926 million from $0.697 million in Q1 2024, r...
09:05am, Tuesday, May 13, 2025
BioForce Nanosciences Reports Financial Struggles Amid Cash Increase and No Sales Revenue in Q1 2025
BioForce Nanosciences Holdings, Inc. (PINK: BFNH) has released its quarterly report for the period ending March 31, 2025, detailing significant financial challenges while navigating the supplement market.
Positive Aspects:
Increase in Assets: Cash increased from $862 at the end of December 2024 ...
09:05am, Tuesday, May 13, 2025
Coya Therapeutics, Inc. (NASDAQ: COYA) reported its quarterly financial results for the period ending March 31, 2025. The company is focused on developing proprietary therapies targeting regulatory T cells to address various diseases.
Key Highlights from the Income Statement:
Collaboration reven...
09:05am, Tuesday, May 13, 2025
Atossa Therapeutics, Inc. (NASDAQ: ATOS) has released its quarterly report for the period ending March 31, 2025. The report highlights continued losses while providing insights into revenue challenges and operational strategies.
Key Financial Highlights:
Net Loss: $6.7 million for Q1 2025, up fr...
09:04am, Tuesday, May 13, 2025
Verb Technology Company, Inc. (NASDAQ: VERB) has released its financial results for the first quarter of 2025, showcasing significant growth in revenue while still facing challenges in overall profitability.
Key Financial Highlights:
Revenue: $1,305,000 for Q1 2025, up from $7,000 in Q1 2024, re...
09:04am, Tuesday, May 13, 2025
Artelo Biosciences, Inc. (NASDAQ: ARTL) has recently reported financial results for the first quarter ended March 31, 2025. The company continues to focus on developing therapeutics that modulate lipid-signaling pathways, particularly through its key product candidates ART27.13 and ART26.12.
Key ...
09:04am, Tuesday, May 13, 2025
Company Overview:
CG Oncology, Inc. (NASDAQ: CGON) is a late-stage clinical biopharmaceutical company focused on developing its product candidate, cretostimogene grenadenorepvec, for bladder cancer treatment. The company is at a clinical stage and has not yet projected significant revenues withou...
09:03am, Tuesday, May 13, 2025
Company Overview
Lionheart Holdings, Inc. (NYSE: CUB) is a blank check company formed to facilitate a business combination. Incorporated in the Cayman Islands on February 21, 2024, the company has not commenced any operations yet as it aims to identify a target for a business combination. Recent ...
09:03am, Tuesday, May 13, 2025
Candel Therapeutics, Inc. (NASDAQ: CADL) is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies for cancer treatment. As of March 31, 2025, the company reported progress in its clinical trials, ongoing strategic partnerships, and faced various fina...
09:02am, Tuesday, May 13, 2025
Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) has reported its financial results for the first quarter of 2025, amidst challenging market conditions.
Recent developments indicate a consolidation within the company as it continues to navigate adverse market conditions, primarily stemming from a...
09:02am, Tuesday, May 13, 2025
Intelligent Bio Solutions Inc. (NASDAQ: GBS)
Company Overview:
Intelligent Bio Solutions Inc. (INBS) is focused on developing rapid, non-invasive medical testing technologies. They operate mainly through their products such as the Intelligent Fingerprinting Drug Screening System.
Income Statement...
09:02am, Tuesday, May 13, 2025
Company Overview:
Oblong, Inc. (NYSE: OBLG) operates in the technology sector, providing multi-stream collaboration technologies and managed services for video collaboration and network applications.
Financial Overview:
For the quarter ending March 31, 2025, Oblong reported a total revenue of $62...